TP53 and metastatic malignant neoplasm in the lymph nodes: LINE-1 hypomethylation in ESCC has been associated with lymph node metastasis, lymphovascular invasion, increased frequency of TP53 mutations, higher CDK6 protein expression levels and a shorter overall survival [82,83,84].